NDC 0002-7637

ZYPREXA Relprevv

Olanzapine Pamoate

ZYPREXA Relprevv is a Intramuscular Kit in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is .

Product ID0002-7637_0738dd1d-0804-49d5-8521-3a9e9ae52fc3
NDC0002-7637
Product TypeHuman Prescription Drug
Proprietary NameZYPREXA Relprevv
Generic NameOlanzapine Pamoate
Dosage FormKit
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2009-12-11
Marketing CategoryNDA / NDA
Application NumberNDA022173
Labeler NameEli Lilly and Company
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0002-7637-11

1 KIT in 1 CARTON (0002-7637-11) * 2.7 mL in 1 VIAL (0002-7660-01) * 3 mL in 1 VIAL (0002-7622-01)
Marketing Start Date2010-03-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0002-7637-11 [00002763711]

ZYPREXA Relprevv KIT
Marketing CategoryNDA
Application NumberNDA022173
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-03-01

NDC 0002-7637-62 [00002763762]

ZYPREXA Relprevv KIT
Marketing CategoryNDA
Application NumberNDA022173
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-05-08
Marketing End Date2015-08-03

Drug Details

OpenFDA Data

SPL SET ID:f9a73185-88de-4d7b-b3c0-bbf231483241
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 1718932
  • 1718928
  • 1718925
  • 1718930
  • 1718936
  • 1718934
  • NDC Crossover Matching brand name "ZYPREXA Relprevv" or generic name "Olanzapine Pamoate"

    NDCBrand NameGeneric Name
    0002-7635ZYPREXAOlanzapine pamoate
    0002-7636ZYPREXAOlanzapine pamoate
    0002-7637ZYPREXAOlanzapine pamoate

    Trademark Results [ZYPREXA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZYPREXA
    ZYPREXA
    75078626 2072867 Live/Registered
    Eli Lilly and Company
    1996-03-26

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.